Recombinant multi-species APOC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOC2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is secreted in plasma where it is a component of very low density lipoprotein. This protein activates the enzyme lipoprotein lipase, which hydrolyzes triglycerides and thus provides free fatty acids for cells. Mutations in this gene cause hyperlipoproteinemia type IB, characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring upstream apolipoprotein C-IV (APOC4) gene. [provided by RefSeq, Mar 2011]
The Alternative Names of target: APOC2,Apolipoprotein C-II,Apo-CII, ApoC-II,Apolipoprotein C2,APO-CII,APOC-II

Target products collectionGo to APOC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0673-Ab-1/ GM-Tg-hg-SE0673-Ab-2 Human APOC2 protein Human
GM-Tg-rg-SE0673-Ab-1/ GM-Tg-rg-SE0673-Ab-2 Rat APOC2 protein Rat
GM-Tg-mg-SE0673-Ab-1/ GM-Tg-mg-SE0673-Ab-2 Mouse APOC2 protein Mouse
GM-Tg-cynog-SE0673-Ab-1/ GM-Tg-cynog-SE0673-Ab-2 Cynomolgus/Rhesus macaque APOC2 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0673-Ab-1/ GM-Tg-felg-SE0673-Ab-2 Feline APOC2 protein Feline
GM-Tg-cang-SE0673-Ab-1/ GM-Tg-cang-SE0673-Ab-2 Canine APOC2 protein Canine
GM-Tg-bovg-SE0673-Ab-1/ GM-Tg-bovg-SE0673-Ab-2 Bovine APOC2 protein Bovine
GM-Tg-equg-SE0673-Ab-1/ GM-Tg-equg-SE0673-Ab-2 Equine APOC2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0673-Ab-1/ GM-Tg-hg-SE0673-Ab-2; GM-Tg-rg-SE0673-Ab-1/ GM-Tg-rg-SE0673-Ab-2;
GM-Tg-mg-SE0673-Ab-1/ GM-Tg-mg-SE0673-Ab-2; GM-Tg-cynog-SE0673-Ab-1/ GM-Tg-cynog-SE0673-Ab-2;
GM-Tg-felg-SE0673-Ab-1/ GM-Tg-felg-SE0673-Ab-2; GM-Tg-cang-SE0673-Ab-1/ GM-Tg-cang-SE0673-Ab-2;
GM-Tg-bovg-SE0673-Ab-1/ GM-Tg-bovg-SE0673-Ab-2; GM-Tg-equg-SE0673-Ab-1/ GM-Tg-equg-SE0673-Ab-2
Products Name APOC2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name APOC2
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine APOC2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.